OOIR: Observatory of International Research

Papers

(The H4-Index of Brain Pathology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading	349
cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors	158
Neuropathologic features of four autopsied COVID‐19 patients	140
B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis	73
COVID‐19‐related neuropathology and microglial activation in elderly with and without dementia	70
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐19	70
Pathology, diagnostics, and classification of medulloblastoma	66
The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low‐grade gliomas and glioneuronal tumors	66
Loss of capillary pericytes and the blood–brain barrier in white matter in poststroke and vascular dementias and Alzheimer’s disease	58
Brain ischemic injury in COVID‐19‐infected patients: a series of 10 post‐mortem cases	54
The microbiota–microglia axis in central nervous system disorders	50
Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update	47
Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions	45
The role of interferons type I, II and III in myositis: A review	43
Intracranial mesenchymal tumor with FET‐CREB fusion—A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma‐like neoplasms	40
Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy	37
Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia	36
MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3)	35
IL‐1β/IL‐1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha‐Synuclein pathology in the olfactory bulb, substantia nigra and striatum	35
Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer’s disease	35
Chronic sleep deprivation altered the expression of circadian clock genes and aggravated Alzheimer's disease neuropathology	35
Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease	31
Interaction of microglia with infiltrating immune cells in the different phases of stroke	30
Genomic mechanisms in Alzheimer's disease	29
The spectrum of rare central nervous system (CNS) tumors with EWSR1‐non‐ETS fusions: experience from three pediatric institutions with review of the literature	28

Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond	27
Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome	27
TERT promoter mutations in primary and secondary WHO grade III meningioma	27
Biology and grading of pleomorphic xanthoastrocytoma—what have we learned about it?	27